Effusive pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a case series
https://doi.org/10.15829/1728-8800-2022-3021
Abstract
A wide variety of non-pulmonary manifestations of a coronavirus disease 2019 (COVID-19) has enriched clinical performance of cardiac diseases with atypical symptoms. Two COVID-19 cases are presented, where sinus bradycardia and syncope, which are rare in COVID-19, were the leading ones after the infection. The patients had no prior cardiovascular diseases, while the examination did not detected neurological pathology and myocarditis. Echocardiography showed relatively small pericardial effusion, which is supposed to be a cause of the symptoms as the diagnosis to exclude. A local buildup of inflammatory fluid around the sinus node and extensive ganglion plexuses around the atria can possibly affect the automatism and chronotropic compensation in addition to the myocardial inflammation. As part of the treatment against the hydropericardium syndrome, the symptoms disappeared, without reoccurring within subsequent 6-month follow-up. The third clinical case regards the pandemic outbreak, when we could not even suspect that the systemic inflammation would persist for many months after COVID-19 and radiofrequency ablation can lead to sudden cardiac death.
About the Authors
Z. N. Sukmarova
P.V. Mandryka Central Military Clinical Hospital
Russian Federation
Russian Federation
Sukmarova Zulfiya N. — cardiologist, echocardiographer
107014 г. Moscov, Bolshaya Olenya 8а
M. A. Saidova
National Medical Research Center of Cardiology
Russian Federation
Russian Federation
Saidova Marina A. — Doctor of Medical Sciences, Professor, Head of the Department of Functional Diagnostics
Moscow
Yu. V. Ovchinnicov
S.M. Kirov Military Medical Academy
Russian Federation
Russian Federation
Ovchinnikov Yuri V. — Doctor med, Associate Professor, Honored Doctor of the Russian Federation, Head of the Department of Emergency Therapy
Moscow
References
1. Gopinathannair R, Merchant FM, Lakkireddy DR, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020;59(2):329-36. doi:10.1007/s10840-02000789-9.
2. Kochi AN, Tagliari AP, Forleo GB, et al. Cardiac and arrhythmic complications in patients with COVID-19. J Cardiovasc Electrophysiol. 2020;31:1003-8. doi:10.1111/jce.14479.
3. Lei S, Jiang F, Su W. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinical Medicine. 2020;5:100331. doi:10.1016/j.eclinm.2020.100331.
4. Nepogodiev D, Glasbey JC, Li E. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study. Lancet. 2020;396(10243):27-38. doi:10.1016/S0140-6736(20)31182-X.
5. Aghagoli G, Gallo Marin B, Soliman LB, et al. Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review. J Card Surg. 2020;35(6):1302-5. doi:10.1111/jocs.14538.
6. Yu CM, Wong RS, Wu ED, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006;82:140-4. doi:10.1136/pgmj.2005.037515.
7. Ståhlberg M, Reistam U, Fedorowski A, et al. Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome. Am J Med. 2021;134(12):1451-6. doi:10.1016/j.amjmed.2021.07.004.
8. Wang Y, Wang Z, Tse G, et al. Cardiac arrhythmias in patients with COVID-19. J Arrhythmia. 2020;36:827-36. doi:10.1002/joa3.12405.
9. Du Y, Tu L, Zhu P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Resp Crit Care Med. 2020;201(11):1372-9. doi:10.1164/rccm.202003-0543OC.
10. Garcia A, Marquez MF, Fierro EF, et al. Cardioinhibitory syncope: from pathophysiology to treatment-should we think on cardioneuroablation? J Interv Card Electrophysiol. 2020;59(2):441-61. doi:10.1007/s10840-020-00758-2.
11. Amaratunga EA, Corwin DS, Moran L, Snyder R. Bradycardia in Patients with COVID-19: A Calm Before the Storm? Cureus. 2020;12(6):e8599. doi:10.7759/cureus.8599.
12. Chinitz JS, Goyal R, Harding M, et al. Bradyarrhythmias in patients with COVID-19: Marker of poor prognosis? Pacing Clin Electrophysiol. 2020;43(10):1199-204. doi:10.1111/pace.14042.
13. Boriani G, Fauchier L, Aguinaga L. Group ESCSD European Heart Rhythm Association (EHRA) consensus document on management of arrhythmias and cardiac electronic devices in the critically ill and post-surgery patient, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). Europace. 2019;21(1):7-8. doi:10.1093/europace/euy110.
14. Russo V, Pafundi PC, Rapacciuolo A, et al. Arrhythmogenic syncope leading to cardiac rhythm management procedures during COVID-19 lockdown. Expert Rev Med Devices. 2020;17(11):1207-10. doi:10.1080/17434440.2020.1841632.
15. Oates CР, Turagam MK, Musikantow D. Syncope and presyncope in patients with COVID-19. Pacing Clin Electrophysiol. 2020;43(10):1139-48. doi:10.1111/pace.14047.
16. Favas TT, Dev P, Chaurasia RN, et al. Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions. Neurol Sci. 2020;41(12):3437-70. doi:10.1007/s10072-020-04801-y.
17. Chen T, Hanna J, Walsh EE, et al. Syncope, Near Syncope, or Nonmechanical Falls as a Presenting Feature of COVID-19. Ann Emerg Med. 2020;76(1):115-7. doi:10.1016/j.annemergmed.2020.04.037.
18. Ebrille E, Lucciola MT, Amellone C, et al. Syncope as the presenting symptom of COVID-19 infection. HeartRhythm Case Rep. 2020;6(7):363-6. doi:10.1016/j.hrcr.2020.04.015.
19. Canetta C, Accordino S, Buscarini E, et al. Syncope at SARSCoV-2 onset. Auton Neurosci. 2020;229:102734. doi:10.1016/j.autneu.2020.102734.
20. Chi PC, Chi-In L, Jia-Yin HC, et al. Localized pericarditis leading to clinical tamponade with profound shock status and syncope as a major clinical manifestation after posterior wall myocardial infarction–Characterization and descriptive findings by real-time 3-dimensional echocardiography. Case Reports in Clinical Medicine. 2013;2(4):263-6. doi:10.4236/crcm.2013.24072.
21. Oliva PB, Hammill SC, Edwards WD. Electrocardiographic diagnosis of postinfarction regional pericarditis. Ancillary observations regarding the effect of reperfusion on the rapidity and amplitude of T wave inversion after acute myocardial infarction. Circulation.1993;88:896-904. doi:10.1161/01.cir.88.3.896.
Supplementary files
Review
For citations:
Sukmarova Z.N., Saidova M.A., Ovchinnicov Yu.V. Effusive pericarditis in the pathogenesis of cardiac arrhythmias in COVID-19: a case series. Cardiovascular Therapy and Prevention. 2022;21(2):3021. (In Russ.) https://doi.org/10.15829/1728-8800-2022-3021
Views:
654
Email this article 
